Global Neurological Disorder Drugs Market Size

2022-04-21 13:27:21 UTC | Healthcare & Pharmaceuticals

According to a new market research report published by Global Market Estimates, the Global Neurological Disorder Drugs Market is projected to grow at a CAGR value of 5.6% from 2022 to 2027.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Neurological Disorder Drugs Market - Forecast to 2027" https://www.globalmarketestimates.com/market-report/neurological-disorder-drugs-market-3778

 Key Market Insights

·         As per the indication outlook, the Parkinson’s disease segment is expected to grow the fastest in the market from 2022 to 2027

·         The cholinesterase inhibitors segment is expected to be the largest segment in the market from 2022 to 2027 as per the drug class segmentation

·         As per the route of administration, the oral segment is expected to grow the fastest in the market from 2022 to 2027

·         North America (the United States, Canada, and Mexico) will have a dominant share in the Global Neurological Disorder Drugs Market from 2022 to 2027

·         Pfizer Inc, Eli Lilly, and Company, Novartis AG, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd, Allergan, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Endo International plc, Sun Pharmaceutical Industries Ltd, among others are the key players in the global neurological disorder drugs market. 

Indication Outlook (Revenue, USD Billion, 2022 - 2027)

·         Epilepsy

·         Alzheimer’s disease

·         Parkinson’s disease

·         Multiple Sclerosis

·         Cerebrovascular disease

·         Others

Drug Class Outlook (Revenue, USD Billion, 2022 - 2027)

·         Cholinesterase Inhibitors

·         NMDA Receptor Antagonists

·         Antiepileptic

·         Antipsychotic and Antidepressant

·         Others

Route of Administration Outlook (Revenue, USD Billion, 2022 - 2027)

·         Oral

·         Parenteral

·         Others

End-Users Outlook (Revenue, USD Billion, 2022 - 2027)

·         Hospitals

·         Homecare

·         Specialty Clinics

·         Others

Distribution Channel Outlook (Revenue, USD Billion, 2022 - 2027)

·         Hospital Pharmacy

·         Online Pharmacy

·         Retail Pharmacy 

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +16026667238